COVID-19 Opens Bigger Doors for the Expansion of Remote Patient Monitoring (RPM) Technology
Covid19 has understandably brought unexpected changes in many people’s lives. Habitual patterns such as social distancing have become accustomed to society. This opened possibilities for newer means of communication and interaction between patients and hospitals.
FOR IMMEDIATE RELEASE
Gyeonggi-do, South Korea, 8 December 2021 – Since the beginning of the pandemic, it has become clear that Remote Patient Monitoring (RPM) is an ideal type of method in medical practices. The value of RPM became more evident as the number of patients preferring these types of programmes rose during the outbreak. Understandably, RPM is considered a safer and more practical option than visiting hospitals for treatment. The growing medical burden and lack of hospital beds lead to early discharge among patients even before the pandemic so it isn’t surprising why there has been a surge in demand for RPM methods recently. RPM is a smart solution that bridges the gap between patients and doctors when there is a lack of accessibility.
With technological advancements evolving at a rapid pace, consumers are now seeking more convenient and effective products that can cater to their health needs. Addressing the demand for RPM technology, Sky Labs has developed CART-I which is a ring-type medical device for continuous cardiac monitoring without user intervention. It is a one-of-a-kind product aimed to fulfil the health needs of its users.
CART-I’s remote monitoring system works by measuring and collecting the blood flow data with a photoplethysmography sensor 24 hours a day while the ring is worn. It’s fully capable of measuring both PPG and ECG signals to detect atrial fibrillation early on. The data measured by CART-I is transmitted to a mobile device via Bluetooth in real-time. With Sky Labs’ efficient cloud-server data collecting systems, all the health information gathered by CART-I can be delivered directly to physicians. It allows doctors to remotely monitor cardiac conditions for improved diagnostics and patient care.
The main goal of Sky Labs has always been to help patients around the world enjoy their life to full. For that purpose, the company participated in HLTH 2021 in Boston, USA last October. They aimed to introduce the brilliant technology behind CART-I and how it can help RPM systems internationally. CEO of Sky Labs, Jack Lee finished his Tech talk with great success and stated, “It is a novel remote patient monitoring platform with a ring-type medical wearable technology device,” explaining today’s trends in the healthcare industry.
COMPANY MILESTONES: Since its founding in 2015, Sky Labs has continuously received recognition in the medical industry each year. Following the official launch in Korea in 2020, Sky Labs has contracted strategic investment and domestic sales rights with CKG. The company was also hailed the Red Dot 2021 winner this year, as well as the CES® 2022 Innovation Awards Honouree for the brilliant design of CART-I. CART-I has also been included in a clinical trial evaluating the effectiveness of warning patients with atrial fibrillation to take anticoagulants if necessary. This clinical trial is being conducted by Dr. Timothy Betts, a cardiologist, arrhythmia specialist, and professor of medicine at the University of Oxford. In addition, Sky Labs has entered into a contract with Titan Commerce Continental Services, the largest distributor of medical devices in Germany to distribute CART-I in countries such as Germany, Austria, and Switzerland. Sky Labs is taking great strides to enter the global marketplace.
Name: Sunny Choi
Organization: Sky Labs
Address: #703, C’s tower, 58, Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, 13486 Gyeonggi-do, South Korea